Your Location：
Home >
Browse articles >
Effect of PI3K-mediated Nrf2 Phosphorylated Activation in Quercetin in Inhibiting Clivorine-induced Hepatotoxicity
Pharmacology | Updated：2021-02-09
Previous|Next

    • Effect of PI3K-mediated Nrf2 Phosphorylated Activation in Quercetin in Inhibiting Clivorine-induced Hepatotoxicity

    • HAO Zhan-xia , SHI Liang , LU Bin , JI Li-li
    • Chinese Journal of Experimental Traditional Medical Formulae Vol. 25, Issue 5, Pages: 112-118(2019)

    • DOI： 10.13422/j.cnki.syfjx.20190423     

      CLC：

    Scan QR Code

  •  
  •  

  • Full Text(HTML)

  • Figs( 2 ) Tabs( 8 )

  • References

  • Publication Info

  • Metrics

Sections
icon
The trial reading is over, you can activate your VIP account to continue reading.
Deactivate >
icon
The trial reading is over. You can log in to your account, go to the personal center, purchase VIP membership, and read the full text.
Already a VIP member?
Log in >

62

Views

90

Downloads

1

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Mechanism of Quercetin-loaded Exosomes in Improving Testosterone Synthesis in Leydig Cells from Correlation Perspective of "Disease， Syndrome， Formula， and Medicine"
Investigating Mechanism of Quercetin in Inhibiting Malignant Phenotype of Hepatocellular Carcinoma Cells Based on Glycolysis Pathway
Quercetin Ameliorates Gouty Arthritis in Rats via ROS/NLRP3/IL-1β Signaling Pathway
Effect of Quercetin on Improving Myelin Sheath Injury and Neuropsychiatric Symptoms of VaD by Inhibiting Activation of Microglia in mPFC via RIPK1/NLRP3/Caspase-1 Pathway
Quercetin Attenuates Ferroptosis Against LPS-induced Acute Kidney Injury Rats via Modulating Keap1/Nrf2/ARE Pathway

Related Author

WANG Meijing
LAN Xiucheng
WANG Fangyue
ZHANG Jingyi
LI Guangsen
CHANG Degui
YU Xujun
YANG Fang

Related Institution

Chengdu University of TCM
Traditional Chinese Medicine（TCM） Regulating Metabolic Diseases Key Laboratory of Sichuan Province，Hospital of Chengdu University of TCM
Guangxi Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor，Collaborative Innovation Centre of Regenerative Medicine and Medical Bioresource Development and Application Co-constructed by Guangxi Province and Ministry of Education， Guangxi Medical University
Cancer Hospital of Guangxi Medical University
The First Affiliated Hospital of Guangxi Medical University